Home > Qtrly Results > PIRAMAL PHARMA

PIRAMAL PHARMA
Quarterly Results Analysis [Sep2024]

PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹2,242 Cr ₹1,951 Cr ₹2,552 Cr ₹1,959 Cr ₹1,911 Cr ₹1,749 Cr ₹2,164 Cr ₹1,716 Cr
Expenses ₹1,900 Cr ₹1,747 Cr ₹2,022 Cr ₹1,690 Cr ₹1,646 Cr ₹1,617 Cr ₹1,812 Cr ₹1,629 Cr
Operating Income ₹342 Cr ₹204 Cr ₹530 Cr ₹268 Cr ₹266 Cr ₹132 Cr ₹351 Cr ₹87 Cr
Other Income ₹61 Cr ₹20 Cr ₹26 Cr ₹62 Cr ₹49 Cr ₹38 Cr ₹25 Cr ₹83 Cr
Interest ₹108 Cr ₹107 Cr ₹114 Cr ₹106 Cr ₹110 Cr ₹119 Cr ₹104 Cr ₹95 Cr
Depreciation ₹192 Cr ₹185 Cr ₹196 Cr ₹186 Cr ₹185 Cr ₹174 Cr ₹184 Cr ₹164 Cr
Profit Before Tax ₹103 Cr ₹-67 Cr ₹215 Cr ₹5 Cr ₹20 Cr ₹-122 Cr ₹87 Cr ₹-89 Cr
Profit After Tax ₹5 Cr ₹-111 Cr ₹89 Cr ₹-4 Cr ₹-14 Cr ₹-113 Cr ₹42 Cr ₹-106 Cr
EPS ₹0.17 ₹-0.67 ₹0.77 ₹0.08 ₹0.04 ₹-0.81 ₹0.41 ₹-0.74
Industry Peers & Returns1W1M1Y
PIRAMAL PHARMA -4.3% -5.8% 62.2%
SUN PHARMACEUTICAL INDUSTRIES -3.7% -2.5% 31.9%
CIPLA -3.2% 0% 8.2%
DR REDDYS LABORATORIES -2.4% 7.3% 15.3%
ZYDUS LIFESCIENCES 2% 2.3% 37.9%
DIVIS LABORATORIES 2.3% 2.1% 46.9%
MANKIND PHARMA -7.1% 1.2% 20.5%
TORRENT PHARMACEUTICALS -2.1% -2.8% 37.8%
LUPIN -4.3% 3.8% 53.3%

PIRAMAL PHARMA Quarterly Revenues

Revenues
Q-o-Q

14.89 %

Y-o-Y

17.28 %

Quarters Revenues % Change
Sep2024 ₹2,242 Cr
14.89
Jun2024 ₹1,951 Cr
-23.56
Mar2024 ₹2,552 Cr
30.32
Dec2023 ₹1,959 Cr
2.47
Sep2023 ₹1,911 Cr
9.29
Jun2023 ₹1,749 Cr
-19.17
Mar2023 ₹2,164 Cr
26.08
Dec2022 ₹1,716 Cr -

PIRAMAL PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

67.05 %

Y-o-Y

28.60 %

Quarters Operating Profit % Change
Sep2024 ₹342 Cr
67.05
Jun2024 ₹204 Cr
-61.41
Mar2024 ₹530 Cr
97.46
Dec2023 ₹268 Cr
1.03
Sep2023 ₹266 Cr
100.76
Jun2023 ₹132 Cr
-62.33
Mar2023 ₹351 Cr
302.23
Dec2022 ₹87 Cr -
Operating Margins
Q-o-Q

45.42 %

Y-o-Y

9.64 %

Quarters Operating Margin% % Change
Sep2024 15.24%
45.42
Jun2024 10.48%
-49.52
Mar2024 20.76%
51.53
Dec2023 13.7%
-1.44
Sep2023 13.9%
83.62
Jun2023 7.57%
-53.39
Mar2023 16.24%
219.06
Dec2022 5.09% -

PIRAMAL PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Positive

Y-o-Y

Positive

Quarters Profit After Tax % Change
Sep2024 ₹5 Cr
Positive
Jun2024 ₹-111 Cr
Negative
Mar2024 ₹89 Cr
Positive
Dec2023 ₹-4 Cr
Negative
Sep2023 ₹-14 Cr
Negative
Jun2023 ₹-113 Cr
Negative
Mar2023 ₹42 Cr
Positive
Dec2022 ₹-106 Cr -
PAT Margins
Q-o-Q

Positive

Y-o-Y

Positive

Quarters PAT Margin(%) % Change
Sep2024 0.24 %
Positive
Jun2024 -5.69 %
Negative
Mar2024 3.5 %
Positive
Dec2023 -0.2 %
Negative
Sep2023 -0.74 %
Negative
Jun2023 -6.46 %
Negative
Mar2023 1.96 %
Positive
Dec2022 -6.16 % -

PIRAMAL PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Positive

Y-o-Y

325.00 %

Quarters EPS % Change
Sep2024 ₹0.17
Positive
Jun2024 ₹-0.67
Negative
Mar2024 ₹0.77
862.50
Dec2023 ₹0.08
100.00
Sep2023 ₹0.04
Positive
Jun2023 ₹-0.81
Negative
Mar2023 ₹0.41
Positive
Dec2022 ₹-0.74 -

You may also like the below Video Courses